The Claim
In adults with primary hypercholesterolemia, rosuvastatin 40 mg monotherapy is associated with a mean LDL cholesterol reduction of 58.7%, which is significantly greater than the reductions observed with simvastatin 10 mg (32.5%) or other statin doses.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with high cholesterol, taking 40 mg of rosuvastatin alone lowers LDL cholesterol by an average of 58.7%, which is a larger reduction than what is seen with 10 mg of simvastatin or other statin doses.
See the scientific wording
In adults with primary hypercholesterolemia, rosuvastatin 40 mg monotherapy is associated with a mean LDL cholesterol reduction of 58.7%, which is significantly greater than reductions seen with simvastatin 10 mg (32.5%) or other statin doses, suggesting that rosuvastatin at this dose may be more effective for LDL lowering in real-world clinical practice.
Rosuvastatin blocks a key enzyme in the liver that makes cholesterol, causing the liver to pull more bad cholesterol out of the blood by making more receptors that grab it and remove it from circulation.
What the research says
1 studyThe study found that people with high cholesterol who took 40 mg of rosuvastatin lowered their bad cholesterol by almost 59%, which is much more than those who took 10 mg of simvastatin (only 32.5%). So yes, rosuvastatin at this dose works better for lowering cholesterol in real patients.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.